Skip to main content
Iovance expands production facility in Philadelphia
5/30/2019

Iovance Biotherapeutics will build a new facility in Philadelphia that will house the commercial and clinical production of autologous TIL products, including drug candidate lifileucel. The company intends to invest about $75 million for the site.

Full Story: